Drugs Made In America Acquisition Corp. (DMAA) stock
DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)
Close on Nov 17, 2026Market cap $264.62MP/E –Yield –
Drugs Made In America Acquisition revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
No revenue figures for Drugs Made In America Acquisition
Drugs Made In America Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?